{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:21:09Z","timestamp":1786119669537,"version":"build-2736575974"},"reference-count":40,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2011,1,14]]},"DOI":"10.1097\/qad.0b013e328340fdca","type":"journal-article","created":{"date-parts":[[2010,11,12]],"date-time":"2010-11-12T02:17:08Z","timestamp":1289528228000},"page":"171-176","source":"Crossref","is-referenced-by-count":31,"title":["Prospective study of renal function in HIV-infected pediatric patients receiving tenofovir-containing HAART regimens"],"prefix":"10.1097","volume":"25","author":[{"given":"Pere","family":"Soler-Palac\u00edn","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susana","family":"Melendo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antoni","family":"Noguera-Julian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia","family":"Fortuny","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda L","family":"Navarro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda J","family":"Mellado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lourdes","family":"Garcia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonia","family":"Uriona","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Mart\u00edn-Nalda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Concepci\u00f3","family":"Figueras","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-7-20210130","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1001\/jama.292.2.191","article-title":"Efficacy and safety of tenofovir DF vs stavudine in combination therapy in antiretroviral-naive patients: a 3-years randomized trial","volume":"292","author":"Gallant","year":"2004","journal-title":"JAMA"},{"key":"R2-7-20210130","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1097\/INF.0b013e31818c8d2c","article-title":"Tenofovir use in human immunodeficiency virus-1-infected children in the United Kingdom and Ireland","volume":"28","author":"Riordan","year":"2009","journal-title":"Pediatr Infect Dis J"},{"key":"R3-7-20210130","doi-asserted-by":"crossref","first-page":"e846","DOI":"10.1542\/peds.2005-0975","article-title":"Tenofovir disoproxil fumarate and an optimized background regimen of antiretroviral agents as a salvage therapy of pediatric HIV infection","volume":"116","author":"Hazra","year":"2005","journal-title":"Pediatrics"},{"key":"R4-7-20210130","doi-asserted-by":"crossref","first-page":"573","DOI":"10.2165\/00044011-200727080-00006","article-title":"Renal safety of tenofovir in HIV-infected children: a prospective, 96-week longitudinal study","volume":"27","author":"Vigan\u00f2","year":"2007","journal-title":"Clin Drug Investig"},{"key":"R5-7-20210130","doi-asserted-by":"crossref","first-page":"1522","DOI":"10.1056\/NEJMoa011157","article-title":"Effect of combination therapy including protease inhibitors on mortality among children and adolescents infected with HIV-1","volume":"345","author":"Gortmarker","year":"2001","journal-title":"N Engl J Med"},{"key":"R6-7-20210130","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1053\/j.ajkd.2009.07.012","article-title":"Subclinical tubular injury in HIV-infected individuals on antiretroviral therapy: a cross-sectional analysis","volume":"54","author":"Hall","year":"2009","journal-title":"Am J Kidney Dis"},{"key":"R7-7-20210130","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1097\/01.inf.0000055093.42130.40","article-title":"Evaluation of multiple drug therapy in human immunodeficiency virus-infected pediatric patients","volume":"22","author":"King","year":"2003","journal-title":"Pediatr Infect Dis J"},{"key":"R8-7-20210130","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1097\/QAD.0b013e3283333680","article-title":"Effect of tenofovir disoproxil fumarate on risk of renal abnormality in HIV-1-infected children on antiretroviral therapy: a nested case-control study","volume":"24","author":"Judd","year":"2010","journal-title":"AIDS"},{"key":"R9-7-20210130","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1097\/QAD.0b013e328339fe53","article-title":"Estimated glomerular filtration rate, chronic kidney disease and antiretroviral drug use in HIV-positive patients","volume":"24","author":"Mocroft","year":"2010","journal-title":"AIDS"},{"key":"R10-7-20210130","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1097\/00002030-199301000-00024","article-title":"Dideoxyinosine-associated nephrotoxicity","volume":"7","author":"Crowther","year":"1993","journal-title":"AIDS"},{"key":"R11-7-20210130","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.jinf.2005.07.020","article-title":"Is tenofovir involved in hypophosphatemia and decrease of tubular phosphate reabsorption in HIV-positive adults?","volume":"52","author":"Badiou","year":"2006","journal-title":"J Infect"},{"key":"R12-7-20210130","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1111\/j.1468-1293.2009.00716.x","article-title":"Tenofovir-associated renal and bone toxicity","volume":"10","author":"Woodward","year":"2009","journal-title":"HIV Med"},{"key":"R13-7-20210130","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1097\/00126334-200403010-00007","article-title":"Renal tubular dysfunction associated with tenofovir therapy: report of 7 cases","volume":"35","author":"Peyri\u00e8re","year":"2004","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R14-7-20210130","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1111\/j.1468-1293.2005.00318.x","article-title":"The development of hypophosphatemic osteomalacia with myopathy in two patients with HIV receiving tenofovir therapy","volume":"6","author":"Parsonage","year":"2005","journal-title":"HIV Med"},{"key":"R15-7-20210130","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1093\/ndt\/gfh658","article-title":"Long-term safety of tenofovir disoproxil fumarate in antiretroviral-na\u00efve HIV-1-infected patients. Data from a double-blind randomized active-controlled multicentre study","volume":"20","author":"Izzedine","year":"2005","journal-title":"Nephrol Dial Transplant"},{"key":"R16-7-20210130","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1086\/368314","article-title":"Tenofovir-related nephrotoxicity in human immunodeficiency virus-infected patients: three cases of renal failure, Fanconi syndrome, and nephrogenic diabetes insipidus","volume":"36","author":"Karras","year":"2003","journal-title":"Clin Infect Dis"},{"key":"R17-7-20210130","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1097\/00002030-200404300-00019","article-title":"Renal safety of tenofovir in HIV treatment-experienced patients","volume":"18","author":"Izzedine","year":"2004","journal-title":"AIDS"},{"key":"R18-7-20210130","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1097\/QAI.0b013e3181d05579","article-title":"Incomplete reversibility of tenofovir-related renal toxicity in HIV-infected men","volume":"55","author":"Wever","year":"2010","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R19-7-20210130","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1081\/NCN-100002341","article-title":"Human renal organic anion transporter 1 (hOAT1) and its role in the nephrotoxicity of anticiral nucleotide analogs","volume":"20","author":"Cihlar","year":"2001","journal-title":"Nucleosides Nucleotides Nucleic Acids"},{"key":"R20-7-20210130","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1177\/135965350601100108","article-title":"Exploring mitochondrial nephrotoxicity as a potential mechanism of kidney dysfunction among HIV-infected patients on highly active antiretroviral therapy","volume":"11","author":"C\u00f4t\u00e9","year":"2006","journal-title":"Antivir Ther"},{"key":"R21-7-20210130","doi-asserted-by":"crossref","first-page":"e108","DOI":"10.1086\/598507","article-title":"Predictors of kidney tubular dysfunction in HIV-infected patients treated with tenofovir: a pharmacogenetic study","volume":"48","author":"Rodr\u00edguez-Novoa","year":"2009","journal-title":"Clin Infect Dis"},{"key":"R22-7-20210130","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1097\/QAD.0b013e32833202e2","article-title":"Impairment in kidney tubular function in patients receiving tenofovir is associated with higher tenofovir plasma concentrations","volume":"24","author":"Rodriguez-Novoa","year":"2010","journal-title":"AIDS"},{"key":"R23-7-20210130","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1007\/s00467-006-0109-3","article-title":"Nephrotoxicity in a child with perinatal HIV on tenofovir, didanosine and lopinavir\/ritonavir","volume":"21","author":"Hussain","year":"2006","journal-title":"Pediatr Nephrol"},{"key":"R24-7-20210130","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1111\/j.1468-1293.2007.00497.x","article-title":"Adverse events experienced by three children taking tenofovir and didanosine in combination","volume":"8","author":"Hawkins","year":"2007","journal-title":"HIV Med"},{"key":"R25-7-20210130","doi-asserted-by":"crossref","first-page":"e711","DOI":"10.1542\/peds.2005-2525","article-title":"Tenofovir disoproxil fumarate and an optimized background regimen of antiretroviral agents as salvage therapy: impact on bone mineral density in HIV-infected children","volume":"118","author":"Gafni","year":"2006","journal-title":"Pediatrics"},{"key":"R26-7-20210130","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1542\/peds.58.2.259","article-title":"A simple estimate of glomerular filtration rate in children derived from body length and plasma creatinine","volume":"58","author":"Schwartz","year":"1976","journal-title":"Pediatrics"},{"key":"R27-7-20210130","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1016\/S0022-3476(85)80697-1","article-title":"A simple estimate of glomerular filtration rate in adolescent boys","volume":"106","author":"Schwartz","year":"1985","journal-title":"J Pediatr"},{"key":"R28-7-20210130","first-page":"175","article-title":"Reference values of urea, creatinine and creatinine clearance in children and adolescents","volume":"14","author":"Arg\u00fcelles","year":"1994","journal-title":"Nefrolog\u00eda"},{"key":"R29-7-20210130","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1016\/S0272-6386(96)90517-X","article-title":"Low molecular weight proteinuria in human immnodeficiency virus-infected patients","volume":"27","author":"Kabanda","year":"1996","journal-title":"Am J Kidney Dis"},{"key":"R30-7-20210130","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1056\/NEJM198312223092503","article-title":"Use of single voided urine samples to estimate quantitative proteinuria","volume":"309","author":"Ginsberg","year":"1983","journal-title":"N Engl J Med"},{"key":"R31-7-20210130","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1097\/INF.0b013e3181256570","article-title":"Increased beta-2-microglobulinuria in human immunodeficiency virus-1-infected children and adolescents treated with tenofovir","volume":"26","author":"Papaleo","year":"2007","journal-title":"Pediatr Infect Dis J"},{"key":"R32-7-20210130","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1089\/aid.2008.0202","article-title":"Progressive renal tubular dysfunction associated with long-term of tenofovir","volume":"25","author":"Kinai","year":"2009","journal-title":"AIDS Res Hum Retroviruses"},{"key":"R33-7-20210130","first-page":"301","article-title":"Serum hypophosphatemia in tenofovir disoproxil fumarate recipients is multifactorial in origin, questioning the utility of its monitoring in clinical practice","volume":"38","author":"Day","year":"2005","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R34-7-20210130","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/j.amjmed.2004.03.025","article-title":"Tenofovir-associated nephrotoxicity: Fanconi syndrome and renal failure","volume":"117","author":"Rifkin","year":"2004","journal-title":"Am J Med"},{"key":"R35-7-20210130","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1086\/379829","article-title":"Tenofovir-related Fanconi syndrome with nephrogenic diabetes insipidus in a patient with acquired immunodeficiency syndrome: the role of lopinavir-ritonavir-didanosine","volume":"37","author":"Rollot","year":"2003","journal-title":"Clin Infect Dis"},{"key":"R36-7-20210130","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1210\/jc.2003-030767","article-title":"Longitudinal changes of bone mineral density and metabolism in antiretroviral-treated human immunodeficiency virus-infected children","volume":"89","author":"Mora","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"R37-7-20210130","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.1097\/00002030-200109280-00011","article-title":"Bone mineral loss through increased bone turnover in HIV-infected children treated with highly active antiretroviral therapy","volume":"15","author":"Mora","year":"2001","journal-title":"AIDS"},{"key":"R38-7-20210130","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1093\/bmb\/ldp037","article-title":"Bone health in HIV infection","volume":"92","author":"Pollock","year":"2009","journal-title":"Br Med Bull"},{"key":"R39-7-20210130","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1007\/s00198-007-0524-8","article-title":"Risk factors for decreased bone density and effects of HIV on bone in elderly","volume":"19","author":"Jones","year":"2008","journal-title":"Osteoporos Int"},{"key":"R40-7-20210130","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1128\/AAC.48.5.1469-1487.2004","article-title":"Biological effects of short-term or prolonged administration of 9-[2-phosphonometoxy-propyl] adenine (tenofovir) to newborn and infants rhesus macaques","volume":"48","author":"Van Rompay","year":"2004","journal-title":"Antimicrob Agents Chemother"}],"container-title":["AIDS"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00002030-201101140-00007","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T18:42:32Z","timestamp":1786041752000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00002030-201101140-00007"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,1,14]]},"references-count":40,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2011]]}},"URL":"https:\/\/doi.org\/10.1097\/qad.0b013e328340fdca","relation":{},"ISSN":["0269-9370"],"issn-type":[{"value":"0269-9370","type":"print"}],"subject":[],"published":{"date-parts":[[2011,1,14]]}}}